DexCom Total Liabilities and Share Holders Equity 2010-2025 | DXCM
DexCom total liabilities and share holders equity from 2010 to 2025. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
- DexCom total liabilities and share holders equity for the quarter ending March 31, 2025 was $6.752B, a 4.16% increase year-over-year.
- DexCom total liabilities and share holders equity for 2024 was $6.485B, a 3.51% increase from 2023.
- DexCom total liabilities and share holders equity for 2023 was $6.265B, a 16.19% increase from 2022.
- DexCom total liabilities and share holders equity for 2022 was $5.392B, a 9.29% increase from 2021.
| DexCom Annual Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2024 | $6,485 |
| 2023 | $6,265 |
| 2022 | $5,392 |
| 2021 | $4,933 |
| 2020 | $4,291 |
| 2019 | $2,395 |
| 2018 | $1,916 |
| 2017 | $904 |
| 2016 | $403 |
| 2015 | $292 |
| 2014 | $185 |
| 2013 | $123 |
| 2012 | $106 |
| 2011 | $121 |
| 2010 | $77 |
| 2009 | $47 |
| DexCom Quarterly Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2025-03-31 | $6,752 |
| 2024-12-31 | $6,485 |
| 2024-09-30 | $6,354 |
| 2024-06-30 | $6,799 |
| 2024-03-31 | $6,482 |
| 2023-12-31 | $6,265 |
| 2023-09-30 | $6,596 |
| 2023-06-30 | $6,821 |
| 2023-03-31 | $5,516 |
| 2022-12-31 | $5,392 |
| 2022-09-30 | $4,899 |
| 2022-06-30 | $5,217 |
| 2022-03-31 | $5,057 |
| 2021-12-31 | $4,933 |
| 2021-09-30 | $4,776 |
| 2021-06-30 | $4,504 |
| 2021-03-31 | $4,390 |
| 2020-12-31 | $4,291 |
| 2020-09-30 | $3,833 |
| 2020-06-30 | $3,522 |
| 2020-03-31 | $2,448 |
| 2019-12-31 | $2,395 |
| 2019-09-30 | $2,186 |
| 2019-06-30 | $2,066 |
| 2019-03-31 | $1,974 |
| 2018-12-31 | $1,916 |
| 2018-09-30 | $1,114 |
| 2018-06-30 | $1,008 |
| 2018-03-31 | $897 |
| 2017-12-31 | $904 |
| 2017-09-30 | $843 |
| 2017-06-30 | $796 |
| 2017-03-31 | $467 |
| 2016-12-31 | $403 |
| 2016-09-30 | $362 |
| 2016-06-30 | $333 |
| 2016-03-31 | $299 |
| 2015-12-31 | $292 |
| 2015-09-30 | $257 |
| 2015-06-30 | $218 |
| 2015-03-31 | $189 |
| 2014-12-31 | $185 |
| 2014-09-30 | $159 |
| 2014-06-30 | $140 |
| 2014-03-31 | $125 |
| 2013-12-31 | $123 |
| 2013-09-30 | $110 |
| 2013-06-30 | $102 |
| 2013-03-31 | $99 |
| 2012-12-31 | $106 |
| 2012-09-30 | $103 |
| 2012-06-30 | $111 |
| 2012-03-31 | $118 |
| 2011-12-31 | $121 |
| 2011-09-30 | $129 |
| 2011-06-30 | $136 |
| 2011-03-31 | $67 |
| 2010-12-31 | $77 |
| 2010-09-30 | $54 |
| 2010-06-30 | $61 |
| 2010-03-31 | $68 |
| 2009-12-31 | $47 |
| 2009-09-30 | $54 |
| 2009-06-30 | $65 |
| 2009-03-31 | $78 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $34.894B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $180.563B | 21.85 |
| Intuitive Surgical (ISRG) | United States | $177.754B | 73.68 |
| Edwards Lifesciences (EW) | United States | $46.928B | 31.13 |
| IDEXX Laboratories (IDXX) | United States | $45.454B | 52.24 |
| Alcon (ALC) | Switzerland | $45.309B | 30.62 |
| IQVIA Holdings (IQV) | United States | $33.859B | 19.13 |
| Mettler-Toledo (MTD) | United States | $26.270B | 31.24 |
| STERIS (STE) | Ireland | $22.671B | 24.97 |
| Waters (WAT) | United States | $18.028B | 25.44 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.531B | 0.00 |
| Hologic (HOLX) | United States | $14.819B | 16.10 |
| Sysmex ADR (SSMXY) | Japan | $10.682B | 30.30 |
| Penumbra (PEN) | United States | $9.027B | 70.85 |
| Masimo (MASI) | United States | $8.926B | 32.92 |
| Globus Medical (GMED) | United States | $7.375B | 17.57 |
| Glaukos (GKOS) | United States | $5.388B | 0.00 |
| Teleflex (TFX) | United States | $5.179B | 8.55 |
| Integer Holdings (ITGR) | United States | $3.786B | 18.97 |
| TransMedics (TMDX) | United States | $3.657B | 79.50 |
| PROCEPT BioRobotics (PRCT) | United States | $3.083B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.381B | 14.18 |
| Nihon Kohden (NHNKY) | Japan | $2.144B | 24.59 |
| Elekta AB (EKTAY) | Sweden | $1.991B | 17.90 |
| Veracyte (VCYT) | United States | $1.977B | 27.75 |
| Alphatec Holdings (ATEC) | United States | $1.582B | 0.00 |
| Artivion (AORT) | United States | $1.341B | 125.60 |
| OPKO Health (OPK) | United States | $1.086B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.058B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.019B | 5.42 |
| Pulse Biosciences (PLSE) | United States | $1.004B | 0.00 |
| SiBone (SIBN) | United States | $0.735B | 0.00 |
| IRadimed (IRMD) | United States | $0.716B | 36.34 |
| Beta Bionics (BBNX) | United States | $0.643B | 0.00 |
| AxoGen (AXGN) | United States | $0.609B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.555B | 8.64 |
| OrthoPediatrics (KIDS) | United States | $0.553B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.525B | 11.30 |
| Pacific Biosciences Of California (PACB) | United States | $0.462B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.442B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.416B | 9.67 |
| Delcath Systems (DCTH) | United States | $0.397B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.375B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.358B | 0.00 |
| RxSight (RXST) | United States | $0.324B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.314B | 0.00 |
| Neuronetics (STIM) | United States | $0.297B | 0.00 |
| NeuroPace (NPCE) | United States | $0.295B | 0.00 |
| 908 Devices (MASS) | United States | $0.266B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.260B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.245B | 14.86 |
| CVRx (CVRX) | United States | $0.217B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.203B | 0.00 |
| Inogen (INGN) | United States | $0.183B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.180B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.179B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.131B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.120B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.117B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.108B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.108B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.091B | 55.10 |
| EnVVeno Medical (NVNO) | United States | $0.087B | 0.00 |
| Hyperfine (HYPR) | United States | $0.084B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.067B | 0.00 |
| Spectral AI (MDAI) | United States | $0.066B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.053B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.053B | 21.44 |
| EDAP TMS S.A (EDAP) | France | $0.052B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.018B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.013B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.10 |